knowledge

In the converging area where Pharma meets FMCG lies an exciting field brimming with innovation, staggering growth, and new sectors that blur the lines between these industries. Although regulations and limitations rule the manufacturing of many such products, it is worth asking, is packaging in consumer healthcare so different from FMCG, or could we draw parallels between some rules and trends?

This year has proven that in times of crisis, adaptability is the one strength and skill that is key to helping both businesses and individuals cope with the looming uncertainty. In 2020, we grew in the face of challenges while taking care of each other – all 101 of EyeSee team members.

For the second consecutive year, EyeSee has 3 nominations in the finals of Quirk’s Marketing Research and Insight Excellence Awards! We are immensely honored to be shortlisted and our work and collaboration with Twitter to be recognized in this way.

This year, there were plenty of opportunities for brands to take a stand on different social issues. The big question remains – how do you do it right? With many brands missing the mark on socially conscious advertising, EyeSee researchers wanted to turn to behavioral data and see what it has to uncover about crisis messaging and how it affects brand equity. Read on for a deep dive in the results of one of the most extensive mobile behavioral studies, conducted on 1800 respondents in an Instagram environment.

For decades, marketers have realized the massive predictive potential of behavioral research methods. However, as recently as 8 years ago, reaching into the behavioral research toolkit was a rather impractical affair for brands, taking up weeks and big chunks of budget. A clever idea by EyeSee’s founders – to use respondents’ own devices and webcams to follow eye gaze – kickstarted a whole revolution in behavioral research, opening it up to further innovation.

As this challenging year comes to a close, our editorial team at EyeSee sat down to share their favorite content: blogs, webinars, case studies, and videos created and widely disseminated in 2020!

EyeSee obtained a record growth in 2020 in spite of the COVID crisis and kicks off 2021 by broadening its global reach and capabilities by opening a new sales office in Singapore and an operations office in Mexico City. The award-winning company has been steadily doubling in size every year to meet the growing demand for agile & scalable behavioral research from clients such as Twitter, Microsoft, Colgate-Palmolive, J&J, Bayer, Disney, and many more.

The pandemic has propelled us all into an evolving and learning mode; it has pushed both industries and insights providers to consider new approaches as a matter of survival. Within EyeSee, an agile strategy was part of the team’s DNA from the get-go, which is why sourcing out the right talent to shape and handle the growth is key. A new one just joined our ranks: Heather Graham, formerly VP/Client Development at Behaviorally (formerly PRS)!

The world is finally seeing mass roll-outs of the long-awaited COVID-19 vaccines. Yet, skepticism around vaccination is prevalent. From appealing to emotions, sticking to logical arguments, mentioning families, the economy, or national safety – there are many types of messaging governing bodies can use to promote vaccination, but which ones are the most effective? EyeSee conducted a behavioral study to explore how different messaging affects the public attitude towards vaccination.

On a supermarket shelf, the interests of retailers, manufacturers, and consumers converge in the most tangible way – a consumer settles on one out of hundreds of different products at hand, and a decision is made before you know it. But how do you ensure you really understand what happens in front of the shelf? Data about end sales does too little, too late to explain the decision. On the other hand, surveys that promise prediction by relying on stated purchase intent and claims of future behavior are about as reliable as rolling the dice. Enter Behavioral Decision trees.